Archive · 6 Sep 2025

FDA Tightens Control on GLP-1 Drug Ingredient Imports

FDA Tightens Control on GLP-1 Drug Ingredient Imports

The FDA is cracking down on ingredients used in weight loss and diabetes drugs coming into the US.

They're worried that some of these ingredients might be unsafe or fake.

To prevent this, the FDA will now hold shipments at the border if they look suspicious.

Companies importing these ingredients will have to prove their products are safe before they can sell them.

The FDA found problems with many manufacturing sites outside the US.

However, some countries, like Belgium, Canada, China, and India, have sites that meet FDA standards.

Sources